Serum glucagon-like peptide-1 and G-protein-coupled receptor levels are associated with albuminuria and kidney function in type 2 diabetes: A cross-sectional study
Abstract
The relationship of serum glucagon-like peptide-1 (GLP-1) and G-protein-coupled receptor (GPCR) with kidney-related outcomes continues to be poorly studied. The purpose of this study was to determine whether serum GLP-1 and GPCR are related to urinary albumin-to-creatinine ratio (uACR), estimated glomerular filtration rate (eGFR), and cystatin C in patients with type 2 diabetes mellitus (T2DM).
Methods. A total of 150 participants were included in this cross-sectional study and divided into three groups: the healthy subjects (Control group), T2DM patients with albuminuria stage A1 (T2DM-A1 group), and T2DM patients with albuminuria stage A2/A3 (T2DM-A2/A3 group). There were 50 subjects in each group. The clinical information was collected: fasting glucose, HbA1c, insulin, urea, creatinine, eGFR, uACR, cystatin C, GLP-1, and GPCR values. Serum GLP-1, GPCR, and cystatin C were measured using sandwich ELISA kits. Groups were compared using non-parametric testing. Analysis of Spearman correlation was utilized in the diabetic cohort. Linear regression adjusted for age, BMI, diabetes duration, and HbA1c was conducted to identify independent associations of GLP-1 and GPCR with uACR and eGFR.
Results. GLP-1 and GPCR concentrations were gradually increasing from Сontrol group to group T2DM-A1 and group T2DM-A2/A3. Within the diabetic cohort, GLP-1 and GPCR were positively correlated with uACR and cystatin C and negatively correlated with eGFR. After adjustment for covariates, GLP-1 was associated with higher log-transformed uACR (standardized = 0.529, p < 0.001) and lower eGFR (standardized = -0.415, p < 0.001). Similarly, GPCR also showed a positive correlation with log-transformed uACR (standardized = 0.319, p = 0.002) and a negative correlation with eGFR (standardized = -0.365, p = 0.002).
Conclusions. Circulating GLP-1 and GPCR levels were associated with higher albuminuria and lower eGFR in T2DM. GLP-1 demonstrated a stronger association with albuminuria, while GPCR displayed a comparable negative association with kidney function. The study’s findings offer evidence for a cross-sectional GLP-1-GPCR kidney-related biomarker profile that characterizes the albuminuric T2DM phenotype and call for longitudinal studies to confirm the clinical utility of these markers.
Downloads
References
Copyright (c) 2026 Ukrainian Journal of Nephrology and Dialysis

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.














